Genetic variants of PTPN2 are associated with lung cancer risk: a re-analysis of eight GWASs in the TRICL-ILCCO consortium.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28400551)

Published in Sci Rep on April 11, 2017

Authors

Yun Feng1,2,3, Yanru Wang2,3, Hongliang Liu2,3, Zhensheng Liu2,3, Coleman Mills2,3, Younghun Han4, Rayjean J Hung5, Yonathan Brhane5, John McLaughlin6, Paul Brennan7, Heike Bickeboeller8, Albert Rosenberger8, Richard S Houlston9, Neil E Caporaso10, Maria Teresa Landi10, Irene Brueske11, Angela Risch12, Yuanqing Ye13, Xifeng Wu13, David C Christiani14, Christopher I Amos4, Qingyi Wei15,16

Author Affiliations

1: Department of Respiration, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
2: Duke Cancer Institute, Duke University Medical Center, Durham, NC, 27710, USA.
3: Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
4: Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH, 03755, USA.
5: Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
6: Public Health Ontario, Toronto, Ontario, M5T 3L9, Canada.
7: Genetic Epidemiology Group, International Agency for Research on Cancer (IARC), 69372, Lyon, France.
8: Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, 37073, Göttingen, Germany.
9: Division of Genetics and Epidemiology, the Institute of Cancer Research, London, SW7 3RP, UK.
10: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
11: Helmholtz Centre Munich, German Research Centre for Environmental Health, Institute of Epidemiology I, 85764, Neuherberg, Germany.
12: Department of Molecular Biology, University of Salzburg, 5020, Salzburg, Austria.
13: Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
14: Massachusetts General Hospital, Boston, MA 02114, USA, Department of Environmental Health, Harvard School of Public Health, Boston, MA, 02115, USA.
15: Duke Cancer Institute, Duke University Medical Center, Durham, NC, 27710, USA. qingyi.wei@duke.edu.
16: Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA. qingyi.wei@duke.edu.

Articles by these authors

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet (2014) 2.39

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet (2015) 1.34

Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14 463 cases and 44 188 controls. Carcinogenesis (2016) 0.77

A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer. Sci Rep (2016) 0.77

Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep (2017) 0.75

Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog (2017) 0.75

Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs. Mol Carcinog (2016) 0.75

Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival. Int J Cancer (2017) 0.75

A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signaling. Sci Rep (2017) 0.75

Reduced mRNA Expression of Nucleotide Excision Repair Genes in Lymphocytes and Risk of Squamous Cell Carcinoma of the Head and Neck. Carcinogenesis (2017) 0.75

A PGC1β genetic variant associated with nevus count and melanoma mortality. Int J Cancer (2017) 0.75

Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis (2017) 0.75

Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer (2017) 0.75

Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy. Lung Cancer (2017) 0.75

Novel Genetic Variants in the P38MAPK Pathway Gene ZAK and Susceptibility to Lung Cancer. Mol Carcinog (2017) 0.75